A nickel-catalyzed
cross-electrophile coupling reaction between
(hetero)aryl bromides and 2,2-difluorovinyl tosylate is presented.
This protocol provides facile incorporation of the gem-difluorovinyl moiety in organic molecules. The method features mild
reaction conditions, good functional group tolerance, and excellent
yields. Furthermore, mechanistic experiments and DFT studies indicate
a Ni(0)/Ni(II) catalytic cycle, thus differing from the currently
accepted catalytic cycle for nickel-catalyzed C(sp2)–C(sp2) cross-electrophile coupling reactions.
A cross-electrophile
coupling between gem-difluorinated
cyclopropanes and 2,2-difluorovinyl tosylate via dual Ni/Pd cooperative
catalysis under mild reaction conditions is presented. Various structurally
unique organofluorine compounds bearing both monofluoroalkene and gem-difluoroalkene moieties can be effectively afforded
in good yields with a high (Z)-selectivity. The synthetic
utility of this protocol has been successfully demonstrated by the
late-stage modification of a series of complex bioactive molecules.
A ligand-free iron-catalyzed method for the oxygenation of benzylic sp3 C–H bonds by molecular oxygen (1 atm) using a thiyl radical as a cocatalyst has been developed.
A copper-catalyzed
four-component trifluoromethylthio-arylsulfonylation
between styrene derivatives, AgSCF3, aryldiazonium tetrafluoroborates,
and ex situ generated sulfur dioxide (from SOgen) is presented. This
reaction features mild reaction conditions, good functional group
tolerance, a broad substrate scope, good yields, and excellent diastereoselectivity.
Preliminary mechanistic studies revealed that a radical process might
be involved in this transformation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.